Listar por autor "Castro-Iglesias, Ángeles"
Mostrando ítems 21-40 de 56
-
Epidemiology and outcome of HIV-infected patients admitted to the ICU in the current highly active antiretroviral therapy era
Vidal-Cortés, Pablo; Álvarez-Rocha, Luis; Fernández-Ugidos, Paula; Pérez-Veloso, Marcos Antonio; Suárez-Paul, I.M.; Virgós-Pedreira, Alejandra; Pértega-Díaz, Sonia; Castro-Iglesias, Ángeles (Elsevier, 2020-06-08)[Abstract] Purpose: To describe the epidemiology of critical disease in HIV-infected patients during the current highly active antiretroviral therapy (HAART) era and to identify hospital mortality predictors. Methods: ... -
HCV clearance patterns in saliva and serum of patients with chronic HCV infection under interferon plus ribavirin therapy
Diz Dios, P.; Castro-Iglesias, Ángeles; Rodríguez, I.; Reforma, N.G.; Castro, M.; Eirea, M.; Hermida-Prieto, Manuel (Wiley, 2005-03-30)[Abstract] Statements of the problem: Hepatitis C virus (HCV)-RNA is often present in saliva of HCV-infected patients, with plasma viral load being the only known predictable factor. Interferon plus ribavirin therapy ... -
Hemorragia digestiva alta secundaria a sarcoma de Kaposi gástrico y duodenal
Bello, Laura; Pardeiro Pértega, Remedios; Couto Wörner, Ignacio; Vázquez Rodríguez, Pilar; López-Calvo, Soledad; Castro-Iglesias, Ángeles; Mena, Álvaro; Alonso Aguirre, Pedro; Pedreira, José D. (Sociedad Española de Patología Digestiva, 2012) -
Hepatitis E 3ra genotype infection in people living with HIV in Spain
Rivero-Juárez, A.; Frías, Mario; López-López, Pedro; Berenguer, Juan; García, Federico; Macías, Juan; Alcaraz, Begoña; Castro-Iglesias, Ángeles; Caballero-Gómez, Javier; Rivero, Antonio (Frontiers, 2020-09-11)[Abstract] Background: The objective of our study was to assess the prevalence and incidence of HEV in people living with HIV (PLWH) in a Spanish national cohort. Methods: Retrospective longitudinal study including PLWH ... -
High efficacy and tolerability of hepatitis C genotype 2 treatment with direct-acting antivirals in real world: analysis of the Hepa-C Registry
Aranda, E.B.; Mariño, Zoe; Calvo, S.; Carrión, J.A.; Fernández, I.; García-Samaniego, J.; Baliellas, C.; Pascasio, J.M.; Albillos, A.; Carrillo, C.F.; Castro-Iglesias, Ángeles; Planas, J.M.M.; Giner, C.P.; Palomares, J.J.M.; Llaneras, J.; Arenas, J.; Fernández-Bermejo, M.; Fernández, C.; López, R.M.G.; García, P.B.; Romero-Gómez, Manuel; Sáez-Royuela, F. (Elsevier, 2017) -
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4
Mariño, Zoe; Pascasio-Acevedo, Juan M.; Gallego, Adolfo; Diago, Moisés; Baliellas, Carme; Morillas, Rosa; Prieto, Martín; Moreno, José M.; Sánchez-Antolín, Gloria; Vergara, Mercedes; Forné, Monserrat; Fernández, Inmaculada; Castro-Iglesias, Ángeles; Pascual, Sonia; Gómez, Alexandra; Castells, Lluis; Montero, José L.; Crespo, Javier; Calleja, José L.; García-Samaniego, Javier; Carrión, José A.; Arencibia, Ana C.; Blasco, Alejandro; López-Núñez, Carmen; Sánchez Ruano, Juan José; Gea-Rodríguez, Francisco; Giráldez, Álvaro; Cabezas, Joaquín; Hontangas, Vanessa; Torras, Xavier; Castellote, José; Romero-Gómez, Manuel; Turnes, Juan; Artaza, Tomás de; Narváez, Isidro; Cuervas-Mons Martínez, Valentín; Forns, Xavier (Wiley, 2017-05-08)[Abstract] Background and Aims. Hepatitis C (HCV) therapy with Sofosbuvir (SOF)/Simeprevir (SMV) in clinical trials and real‐world clinical practice, showed high rates of sustained virological response (SVR) in non‐cirrhotic ... -
Impact of HCV infection in a HIV cohort followed over18 years: past and present
Mena, Álvaro; Rodríguez-Osorio, Iria; Meijide, Héctor; Castro-Iglesias, Ángeles; López-Calvo, Soledad; Vázquez Rodríguez, Pilar; Pernas, Berta; Grandal, Marta; Pedreira, José D. (Elsevier, 2015-04) -
Impact of HIV infection on sustained virological response to treatment against hepatitis C virus with pegylated interferon plus ribavirin
Monje-Agudo, P.; Castro-Iglesias, Ángeles; Rivero-Juárez, A.; Martínez-Marcos, F.; Ortega-González, E.; Real, L.M.; Pernas, Berta; Merchante, N.; Cid-Silva, Purificación; Macías, J.; Merino, M.D.; Rivero, A.; Mena, Álvaro; Neukam, K.; Pineda, J.A. (Springer, 2015-07-09)[Abstract] It is commonly accepted that human immunodeficiency (HIV) coinfection negatively impacts on the rates of sustained virological response (SVR) to therapy with pegylated interferon plus ribavirin (PR). However, ... -
Increasing incidence of cancer in persons living with HIV coinfected with HCV: an additional impact of HCV infection?
Mena, Álvaro; Meijide, Héctor; Rodríguez-Osorio, Iria; Castro-Iglesias, Ángeles; Pértega-Díaz, Sonia; Rodríguez-Martínez, Guillermo; Pernas, Berta; Baliñas, Josefa; Pedreira, José D.; Poveda, Eva (Elsevier, 2016) -
Influence of drug–drug interactions on effectiveness and safety of direct-acting antivirals against hepatitis C virus
Margusino-Framiñán, Luis; Cid-Silva, Purificación; Giménez-Arufe, Víctor; Mondelo-García, Cristina; Fernández-Oliveira, Carla; Mena, Álvaro; Martín-Herranz, Isabel; Castro-Iglesias, Ángeles (BMJ, 2019-06-13)[Abstract] Objectives Direct-acting antivirals are the recommended treatment for hepatitis C-infected patients. Drug–drug interactions with concomitant treatments can cause lack of effectiveness and/or safety. The objective ... -
Late HIV diagnosis but earlier antiretroviral treatment initiation in northwest Spain: impact of current treatment guidelines
Cid-Silva, Purificación; Margusino-Framiñán, Luis; Balboa-Barreiro, Vanesa; Pernas, Berta; Mena, Álvaro; Martín-Herranz, Isabel; Castro-Iglesias, Ángeles; Poveda, Eva (Sage, 2019-01-10)[Abstract] Background: Current HIV treatment guidelines recommend antiretroviral treatment (ART) initiation for all HIV-infected individuals regardless of CD4 count. This study evaluates the immunological and virological ... -
Liver toxicity and risk of discontinuation in HIV/hepatitis C virus-coinfected patients receiving an etravirine-containing antiretroviral regimen: influence of liver fibrosis
Casado, José Luis; Mena, Álvaro; Bañón, S; Castro-Iglesias, Ángeles; Quereda, C; Moreno, A; Pedreira, José D.; Moreno, S (Wiley, 2015-06-30)[Abstract] Objectives. The aim of the study was to establish the risk of liver toxicity in HIV/hepatitis C virus (HCV)-coinfected patients receiving etravirine, according to the degree of liver fibrosis. Methods. A ... -
Liver-related events and mortality among elderly patients with advanced chronic hepatitis C treated with direct-acting antivirals
Rodríguez-Osorio, Iria; Mena, Álvaro; Meijide, Héctor; Morano, Luis; Delgado, Manuel; Cid-Silva, Purificación; Margusino-Framiñán, Luis; Pedreira, José D.; Castro-Iglesias, Ángeles (Plos ONE, 2019-06-03)[Abstract] BACKGROUND: Direct-acting antivirals (DAAs) are effective in patients aged ≥65 years. However, little is known about the effects of DAAs on survival, liver decompensation and development of hepatocellular ... -
Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV
Mena, Álvaro; Meijide, Héctor; Rodríguez-Osorio, Iria; Castro-Iglesias, Ángeles; Poveda, Eva (Wiley, 2017-02-23)[Abstract] Objectives. The aim of this study was to compare liver-related mortality and liver-related hospitalizations for persons living with HIV (PLWH) with and without hepatitis C virus (HCV) exposure, and to estimate ... -
Long-term benefits of nevirapine-containing regimens: multicenter study with 506 patients, followed-up a median of 9 years
Podzamczer, D.; Tiraboschi, J.M.; Mallolas, J.; Curto, J.; Cardenes, M.A.; Casas, E.; Castro-Iglesias, Ángeles; Echevarría, S.; Leal, M.; López Bernaldo de Quirós, J.C.; Moreno, S.; Puig, T.; Ribera, E.; Villalonga, C.; Gómez-Sirvent, J.L.; García-Henarejos, J.A.; López-Aldeguer, J.; Barrufet, P.; Force, L.; Santos, I.; Sanz, J. (Bentham, 2012-09)[Abstract] OBJECTIVE: To evaluate long-term outcomes in patients maintaining a nevirapine (NVP)-based regimen. METHODS: Retrospective, multicenter, cohort study including patients currently receiving an NVP regimen that ... -
Long-term clinical experience with darunavir (2007–2015) in a large cohort of HIV-infected patients in Spain authors
Pernas, Berta; Grandal, Marta; Tabernilla, Andrés; Cid-Silva, Purificación; Pértega-Díaz, Sonia; Castro-Iglesias, Ángeles; Mena, Álvaro; Margusino-Framiñán, Luis; Pedreira, José D.; Poveda, Eva (Wiley, 2016-06-06)[Abstract] The clinical experience with the protease inhibitor darunavir/ritonavir (DRV/r) was retrospectively evaluated in a cohort of 173 HIV+ patients who initiated antiretroviral treatment including DRV/r (period ... -
Metabolic syndrome association with fibrosis development in chronic hepatitis B virus inactive carriers
Mena, Álvaro; Pedreira, José D.; Castro-Iglesias, Ángeles; López, Soledad; Vázquez-Rodríguez, Pilar; Poveda, Eva (Wiley, 2013-12-19)[Abstract] Background and Aim. There are few data of fibrosis development in chronic hepatitis B (CHB) patients classified as inactive carriers. The aim of this study is to determinate the prevalence of significant fibrosis ... -
Molecular characterization of HIV-1 infection in Northwest Spain (2009–2013): investigation of the subtype F outbreak
Paraskevis, Dimitrios; Kostaki, Evangelia; Beloukas, Apostolos; Cañizares, Angelina; Aguilera, Antonio; Rodríguez, Javier; Grandal, Marta; Pernas, Berta; Castro-Iglesias, Ángeles; Mena, Álvaro; Pedreira, José D.; Poveda, Eva (Elsevier, 2014-12-16)[Abstract] Background. HIV-1 subtype B is the predominant one in European regions several, while other subtypes and recombinants are also circulating with high prevalence. A sub-epidemic of subtype F with specific ... -
Neoplasias en pacientes con infección por VIH: estudio descriptivo de 129 casos en el período 1993-2010
Meijide, Héctor; Mena, Álvaro; Pernas, Berta; Castro-Iglesias, Ángeles; López, Soledad; Vázquez-Rodríguez, Pilar; Bello, Laura; Baliñas, Josefa; Rodríguez-Martínez, Guillermo; Pedreira, José D. (Sociedad Chilena de Infectología, 2013)[Resumen] Introducción: Uno de los problemas asociados a la infección por VIH es el desarrollo de neoplasias. La incidencia y espectro de los distintos cánceres se ha visto modificada con la incorporación del tratamiento ... -
Phylogeny and phylogeography of a recent HIV-1 subtype F outbreak among men who have sex with men in Spain deriving from a cluster with a wide geographic circulation in western Europe
Delgado, Elena; Cuevas, María Teresa; Domínguez, Francisco; Vega, Yolanda; Cabello, Marina; Fernández-García, Aurora; Pérez-Losada, Marcos; Castro-Iglesias, Ángeles; Montero, Vanessa; Sánchez, Mónica; Mariño, Ana; Álvarez, Hortensia; Ordoñez, Patricia; Ocampo, Antonio; Miralles, Celia; Pérez-Castro, Sonia; López-Álvarez, María José; Rodríguez, Raúl; Trigo, Matilde; Diz-Arén, Julio; Hinojosa, Carmen; Bachiller, Pablo; Hernáez-Crespo, Silvia; Cisterna, Ramón; Garduño, Eugenio; Pérez-Álvarez, Lucía; Thomson, Michael M. (PLOS, 2015-11-24)[Abstract] We recently reported the rapid expansion of an HIV-1 subtype F cluster among men who have sex with men (MSM) in the region of Galicia, Northwest Spain. Here we update this outbreak, analyze near full-length ...